Maryles Joel Michael

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 22% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Maryles Joel Michael's trades of Chemomab Therapeutics Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-25 2022-05-24
B Purchase
92,752 -32.8%
420.89
US$4,158,236 		92,752 -32.8% 420.89 US$4,158,236
2022-05-25 2022-05-24
B Purchase
44,919 -35.3%
219.28
US$4,534,917 		44,919 -35.3% 219.28 US$4,534,917
2022-03-21 2022-03-18
B Purchase
72,244 +6.8%
128.51
US$2,058,026 		72,244 +6.8% 128.51 US$2,058,026
2022-03-21 2022-03-18
B Purchase
500 +inf%
4.32
US$2,160 		500 +inf% 4.32 US$2,160